The scope is a provider-based Single Point of Access (SPoA), clinical triage, Advice and Guidance (A&G), referral navigation and Tier 2 assessment, treatment and follow-up for ENT, dermatology and gynaecology. Referrals will be received through e-RS. Existing commissioned Tier 2 and diagnostic capacity will be used first where clinically appropriate and available with the chosen provider supplying additional Tier 2 capacity where required. Patient choice and timely escalation into secondary care remain core requirements. The proposed contract is being procured as a call-off following a further competition under the Countess of Chester Hospital NHS Foundation Trust Outsourced Clinical Services Framework (F/098/CS/25/IB).

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority at [email protected] by midnight at the end of 26 October 2026. Representations can only be made by providers party to the framework agreement. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR. The award decision-makers were: Associate Director of Integrated Commissioning - NHS Cheshire and Merseyside; IRM Programme Lead - NHS Cheshire and Merseyside; Associate Director - Digital & Data Platforms -- NHS Cheshire and Merseyside; Associate Medical Director Quality and Strategic Commissioning - Cheshire and Merseyside ICB; Consultant and Clinical Director - Alder Hey Children's Hospital NHS Foundation Trust. There were no declared conflicts or potential conflicts of interest of individuals making the decision. The Key Criteria and their relative importance used to make a decision were: Clinical delivery and governance (Quality & Innovation Key Criterion) 20% Mobilisation and implementation (Quality & Innovation Key Criterion) 15% Innovation, evaluation and learning (Quality & Innovation Key Criterion) 5% Value 25% Integration, local Tier 2 first and system sustainability (Integration, Collaboration & Service Sustainability Key Criterion) 15% Access, inequalities and patient choice (Improving Access, Reducing Health Inequalities & Facilitating Choice Key Criterion) 10% Social Value 10% Each of the 5 Key Criteria elements were weighted in consideration of the subject-matter and with a view to securing the needs of the people who use the services, improving the quality of the services, and improving the efficiency of in the provision of the services. Following individual evaluation and panel moderation, the chosen framework provider's tender met the published requirements and was considered capable of delivering the service. Qualitative consensus scores were either satisfactory or good. No moderated criteria was scored poor or unacceptable.

The scope is a provider-based Single Point of Access (SPoA), clinical triage, Advice and Guidance (A&G), referral navigation and Tier 2 assessment, treatment and follow-up for ENT, dermatology and gynaecology. Referrals will be received through e-RS. Existing commissioned Tier 2 and diagnostic capacity will be used first where clinically appropriate and available with the chosen provider supplying additional Tier 2 capacity where required. Patient choice and timely escalation into secondary care remain core requirements. This notice is an intention to award a contract based on a framework agreement under the competitive process. The proposed contract is being procured as a call-off following a further competition under the Countess of Chester Hospital NHS Foundation Trust Outsourced Clinical Services Framework (F/098/CS/25/IB). The proposed contract is a new service. The proposed provider is a new provider. Services are intended to be provided for a period of 6 months from 1 November 2026 (subject to conclusion of standstill) and may be extended for a further 6 months. Options: The proposed contract may be extended for six months to 31 October 2027, subject to confirmed funding and separate ICB approval.

Public Contracts Regulations 2015 (Directive 2014/24/EU)

Award procedure without prior publication of a call for competition This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight at the end of 26 October 2026. Representations can only be made by providers party to the framework agreement. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Lot 1: Bids: 1